Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Herz ; 40(7): 972-9, 2015 Nov.
Artigo em Alemão | MEDLINE | ID: mdl-26530283

RESUMO

The use of left ventricular assist devices (LVAD) as a treatment for severe heart failure has gained momentum in recent years. Even at this stage the number of worldwide LVAD implantations far exceeds the volume of heart transplantations in view of the chronic shortage of donor organs. Third generation continuous flow assist devices have helped to improve survival, quality of life and symptom burden of heart failure patients in comparison to a regimen of optimal medication management. Alongside bridging to transplantation, destination therapy has become an established strategy of LVAD implantation. A careful patient selection process is crucial for a good clinical outcome after device implantation and risk assessment for postoperative right ventricular failure is of particular importance in this context. The rate of hospitalization during LVAD support is still high, despite the step-wise attempts to widen the indications to less severely ill heart failure patients. An effective perioperative and postoperative management will help to lower the incidence of complications (e.g. bleeding, infections, thromboembolic events and right ventricular failure) and to improve the encouraging results of mechanical circulatory support.


Assuntos
Insuficiência Cardíaca/complicações , Insuficiência Cardíaca/prevenção & controle , Seleção de Pacientes , Disfunção Ventricular Esquerda/etiologia , Disfunção Ventricular Esquerda/prevenção & controle , Desenho de Equipamento , Análise de Falha de Equipamento , Medicina Baseada em Evidências , Ventrículos do Coração , Coração Auxiliar , Humanos , Avaliação da Tecnologia Biomédica , Resultado do Tratamento
2.
Herz ; 35(5): 317-23, 2010 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-20814657

RESUMO

BACKGROUND: The intracoronary application of autologous bone marrow cells has proven hitherto to be safe but not sufficiently effective in patients with ischemic cardiomyopathy. The interventional application of cells injected directly into the myocardium represents one possible approach to improve effectiveness. TECHNIQUES: The NOGA method is based on the CARTO technique, which has been evaluated extensively for safety and feasibility in patients with heart failure. In a first step, an electrically and anatomically exact map of the left ventricle is obtained. Guided by this three-dimensional map direct injection of the cells into the ischemic area can be easily performed. CLINICAL STUDIES: Since its introduction in 2002 many studies have proven the safety, feasibility and effectiveness of NOGA-guided regenerative therapy to the left ventricle. While several studies also suggest effectiveness regarding various parameters of left ventricular function, no larger multicenter study is available to date. Such studies with also clinical endpoints are currently ongoing. CONCLUSION: The currently available data support, but do not yet prove, the hypothesis that intramyocardial stem cell therapy using NOGA-guided injection into the myocardium is safe and feasible in both acute and chronic ischemic cardiomyopathy. Ongoing trials will reveal whether this approach will become the standard form for applying cell therapy to the heart.


Assuntos
Transplante de Medula Óssea/métodos , Insuficiência Cardíaca/terapia , Infarto do Miocárdio/terapia , Isquemia Miocárdica/terapia , Estudos de Viabilidade , Seguimentos , Regeneração Tecidual Guiada , Insuficiência Cardíaca/fisiopatologia , Humanos , Injeções Intramusculares , Infarto do Miocárdio/fisiopatologia , Isquemia Miocárdica/fisiopatologia , Disfunção Ventricular Esquerda/fisiopatologia , Disfunção Ventricular Esquerda/terapia , Função Ventricular Esquerda/fisiologia
3.
Free Radic Biol Med ; 31(3): 345-54, 2001 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-11461772

RESUMO

Because increased oxidation is an important feature of Alzheimer's disease (AD) and low concentrations of antioxidant vitamins C and E have been observed in cerebrospinal fluid (CSF) of AD patients, supplementation with these antioxidants might delay the development of AD. Major targets for oxidation in brain are lipids and lipoproteins. We studied whether supplementation with antioxidative vitamins E and C can increase their concentrations not only in plasma but also in CSF, and as a consequence decrease the susceptibility of lipoproteins to in vitro oxidation. Two groups, each consisting of 10 patients with AD, were for 1 month supplemented daily with either a combination of 400 IU vitamin E and 1000 mg vitamin C, or 400 IU vitamin E alone. We found that supplementation with vitamin E and C significantly increased the concentrations of both vitamins in plasma and CSF. Importantly, the abnormally low concentrations of vitamin C were returned to normal level following treatment. As a consequence, susceptibility of CSF and plasma lipoproteins to in vitro oxidation was significantly decreased. In contrast, the supplementation with vitamin E alone significantly increased its CSF and plasma concentrations, but was unable to decrease the lipoprotein oxidizability. These findings document a superiority of a combined vitamin E + C supplementation over a vitamin E supplementation alone in AD and provide a biochemical basis for its use.


Assuntos
Doença de Alzheimer/sangue , Doença de Alzheimer/tratamento farmacológico , Antioxidantes/uso terapêutico , Ácido Ascórbico/uso terapêutico , Lipoproteínas/sangue , Vitamina E/uso terapêutico , Idade de Início , Idoso , Doença de Alzheimer/líquido cefalorraquidiano , Apolipoproteína A-I/sangue , Apolipoproteínas B/sangue , Apolipoproteínas E/sangue , Apolipoproteínas E/líquido cefalorraquidiano , Ácido Ascórbico/sangue , Ácido Ascórbico/líquido cefalorraquidiano , Colesterol/sangue , Colesterol/líquido cefalorraquidiano , Suplementos Nutricionais , Quimioterapia Combinada , Ácidos Graxos não Esterificados/sangue , Ácidos Graxos não Esterificados/líquido cefalorraquidiano , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Tempo , Triglicerídeos/sangue , Triglicerídeos/líquido cefalorraquidiano , Vitamina E/sangue , Vitamina E/líquido cefalorraquidiano
4.
Endoscopy ; 10(2): 71-4, 1978 May.
Artigo em Inglês | MEDLINE | ID: mdl-95946

RESUMO

Excitants of disease can be transmitted by endoscopes from one patient to another. Owing to their complicated construction and the heat-sensitive material fiber glass endoscopes are difficult to disinfect or sterilize. Of the known procedures of sterilization only gas sterilization with ethylene oxide can be used. Clinical examinations and laboratory experiments demonstrate the reliable efficacy of this procedure of sterilization of fiber glass endoscopes. On account of known risks the indications for gas sterilization are compiled.


Assuntos
Endoscópios , Óxido de Etileno , Esterilização/métodos , Bactérias/efeitos dos fármacos , Bactérias/isolamento & purificação , Endoscopia/efeitos adversos , Tecnologia de Fibra Óptica/instrumentação , Gastroenteropatias/diagnóstico , Humanos , Controle de Infecções , Esterilização/normas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA